Norway· NO-ID_44A49196-4FB6-4613-8638-EF54E5F5E562
Jinarc
A tolvaptan product containing tolvaptan, registered in Norway by Otsuka Pharmaceutical Netherlands B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tolvaptan is registered in 13 of 19 countries.
Countries holding a registration under ATC C03XA01 (tolvaptan), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Tolvaptan · ATC C03XA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of tolvaptan costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $1.82 in Czechia to $127.86 in Italy — a ×70 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tolvaptan · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- IT Italy$127.86
- CH Switzerland$72.80
- FR France$14.28
- CZ Czechia$1.82
The record
At a glance
FEST (Norway)- Active substance
- Tolvaptan
- Manufacturer
- Otsuka Pharmaceutical Netherlands B.V.
- Country
- Norway (NO)
- ATC code
- C03XA01
- ATC class
- Tolvaptan
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 1
- no_merkevare_idID_44A49196-4FB6-4613-8638-EF54E5F5E562
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
183 interactions on record for tolvaptan.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolvaptan · interactions on record
183 records
- 16 severe
- 161 moderate
- 6 minor
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- Darunavir and cobicistatJ05AR14severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tolvaptan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomJinarc 90mg tabletsOtsuka Pharmaceuticals (U.K.) Ltd
- United StatesTolvaptanAscend Laboratories, LLC
- SwitzerlandJinarc
- SwedenJinarc 90 mg + 30 mg TablettOtsuka Pharmaceutical Netherlands B.V.
- NetherlandsJinarc 90 mg, tabletOtsuka Pharmaceutical Netherlands B.V.
- IcelandJinarcOtsuka Pharmaceutical Netherlands B.V.*
- CzechiaJINARCOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- SpainJINARC 15 mg + 45 mg COMPRIMIDOSOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Tolvaptan, Tolvaptan +pharma
- Belgium · Tolvaptan, Tolvaptan Eg
- Czechia · Tolvaptan Stada
- Germany · Tolvaptan, Tolvaptan 1 A Pharma
- Estonia · Tolvaptan Stada
- Spain · Tolvaptán Sandoz, Tolvaptan Stadafarma
- France · Tolvaptan Biogaran, Tolvaptan Eg
- United Kingdom (Northern Ireland) · Tolvaptan, Tolvaptan Genus Pharmaceuticals
- Greece · Gurdatol, Pokydy
- Croatia · Gurdatol
- Ireland · Tolvaptan Ascend
- Iceland · Gurdatol, Jinarc
- Italy · Tolvaptan Teva, Tolvaptan Teva Italia
- Liechtenstein · Jinarc, Samsca
- Lithuania · Tolvaptan Stada
- Latvia · Tolvaptan Stada
- Netherlands · Tolvaptan Sandoz, Tolvaptan Teva
- Poland · Tolvaptan Sandoz
- Portugal · Tolvaptano Stada, Tolvaptano Stada 15 Mg + 45 Mg Comprimidos
- Sweden · Tolvaptan Hexal, Tolvaptan Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e06f6e30-7c9c-486d-acc1-3c6b25086b27 GET /v1/drugs/e06f6e30-7c9c-486d-acc1-3c6b25086b27?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Tolvaptan",
"merkevare_id": "ID_44A49196-4FB6-4613-8638-EF54E5F5E562",
"name_form_strength": "Jinarc tab 90 mg",
"prescription_group": "C"
}See everything about tolvaptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.